Načítá se...
Correlation between Galectin-3 and Adverse Outcomes in Myocardial Infarction Patients: A Meta-Analysis
BACKGROUND: Acute myocardial infarction (AMI) is a disease with high morbidity and mortality. Some new biomarkers can help us to improve the life quality and prognosis of AMI patients. OBJECTIVE: We therefore performed a systematic review and meta-analysis on the use of galectin-3 (gal3) for assessi...
Uloženo v:
| Vydáno v: | Cardiol Res Pract |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Hindawi
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7229552/ https://ncbi.nlm.nih.gov/pubmed/32455000 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/7614327 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|